Minerva Biotechnologies

Exploring the Space between Stem Cells and Cancers

  • Cancer Therapeutics
  • Stems Cells & Reagents

Show me more

Latest Products

News

  • New job posting - Ph. D. level scientists

    New job posting – Ph. D. level scientists

    Minerva is a rapidly growing company with world leading stem cell technology and soon to enter into clinical trials with the largest novel cancer targets in the world.  Minerva is interested in employing the best and brightest scientists with a desire to be working in an innovative and fast moving company operating in the vanguard of […]

    Read More

  • Minerva to Present at Needham & Company's 15th Annual Healthcare Conference

    Minerva to Present at Needham & Company’s 15th Annual Healthcare Conference

    Dr. Cynthia Bamdad, CEO and Founder of Minerva Biotechnologies, will be speaking at Needham and Company’s 15th Annual Healthcare Conference in New York City at 2pm on Wednesday, April 13th.  Her talk will take place in the Private Company Track of the conference.

    Read More

  • Minerva Discovers Naïve Stem Cell Growth Factor

    Minerva Discovers Naïve Stem Cell Growth Factor

    WALTHAM, Mass.–(BUSINESS WIRE)–Minerva Biotechnologies, a leading cancer and stem cell development company announces publication of their latest research article in the journal Stem Cells: “A Primitive Growth Factor, NME7-AB, Is Sufficient to Induce Stable Naïve State Human Pluripotency; Reprogramming in This Novel Growth Factor Confers Superior Differentiation” DOI: 10.1002/stem.2261. This article reports a major breakthrough […]

    Read More